April 29, 2021
By Jill K. MacAlpine, Ph.D.; Alissa K. Lipton; Sara A. Leiman, Ph.D.; Oulu (Lulu) Wang, Ph.D.
The Life Sciences industry can be particularly challenging for companies to navigate, often requiring careful navigation through rigorous testing and regulatory compliance. The Life Sciences Podcasts Series looks at some of the hottest topics in the Life Sciences industry. In this podcast, Finnegan attorneys Jill MacAlpine, Alissa Lipton, Lulu Wang, and Sara Leiman discuss the doctrine of inherency and obviousness and identify notable, recent decisions in the life sciences industry.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology Patent Law
April 27, 2023
Cambridge
March 22-23, 2023
Virtual
Webinar
March 21, 2023
Webinar
Conference
March 21-22, 2023
Boston
Federal Circuit IP Blog
Dietary Supplement Patent Invalid Under 35 U.S.C. § 101, Federal Circuit Affirms
March 17, 2023
Prosecution First Blog
ChromaDex Fails to Milk Its Patent for Subject Matter Eligibility
March 17, 2023
Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
The Finnegan UPC Hub is a one-stop shop for our insights related to the Unified Patent Court (UPC).